Background/purpose It was found that body temperature would be gradually increased during pediatric full mouth rehabilitation surgery. Although the etiology is unknown, here, we introduced an effective method to maintain normothermia during this kind of surgery. Materials and methods Following IRB approval, the medical records of pediatric patients who received full mouth rehabilitation surgery from Jan. 2014 through Jun. 2016 were collected. All the patients included were managed by a “tent-like draping” with a forced-air warmer (Life-Air 1000, Progressive Dynamics Inc.). The temperature of the forced-air was changed from 38 °C to cool ambient temperature when the body temperature higher than 36 °C. The body temperatures (preoperative, periodic during operation, and postoperative) and the maximum body temperature changes during operation were recorded. The data was compared with the results of a previous report. Results: Total 37 patients were enrolled. The maximum temperature change during operation was 2.08 ± 0.6 °C. The incidence of body temperature higher than 37.5 °C during operation was 10.8% (4/37). Compare to the previous report in which the patients received the same operation with ordinary surgical draping, the maximum temperature change and the incidence of body temperature higher than 37.5 °C during operation were significantly lower in patients received “tent-like draping” (2.08 ± 0.64 °C vs 2.50 ± 1.17 °C, p < 0.001; and 10.8% (4/37) vs 32.4% (11/34), p < 0.05, respectively) Conclusion: The increase of body temperature during pediatric full mouth rehabilitation surgery can be effectively controlled by ambient forced-air cooling using tent-like draping.
2 February 2024 in Journal of the Taiwan Institute of Chemical Engineers
Mesenchymal stem cells exhibit therapeutic efficacy for brain injury. This study examined the effect of mesenchymal stem cells derived from human exfoliated deciduous teeth (SHED) on alleviating symptoms of Parkinson's disease (PD). SHED were isolated to examine the biosafety and bioavailability of stem cells derived from human exfoliated deciduous teeth-derived conditioned medium (SHED-CM) for the alleviation of PD symptoms in a 6-hydroxydopamine (6-OHDA)-induced PD zebrafish model. SHED-CM administration did not induce neurological, skin or muscle toxicity in control zebrafish at any dose, and estrogen equivalent testing showed no chronic toxicants. Induction of PD with 6-OHDA suppressed zebra SHED-CM was administered to zebrafish treated with 6-OHDA to induce PD symptoms. Similar to nomifensine, a drug with proven anti-PD potential, SHED-CM repaired the motor deficiencies in the zebrafish PD model. Our results indicate the biosafety of SHED-CM and its therapeutic potential in treating PD in a zebrafish model.
Extracellular matrix (ECM) may be useful as a natural scaffold for tissue engineering. Since dental follicle stem cells (DFSCs) share a similar embryonic origin with corneal keratocytes and endothelial cells and possess the ability to proliferate and differentiate, in this study, we investigate the potential of DFSCs to differentiate into corneal cells under the supercritical carbon dioxide (SC–CO2) decellularized porcine corneal ECM culture stimulation. DFSCs were seeded onto the SC-CO2 decellularized porcine corneal ECM and the surrounding culture dish for 21 days. Cell morphology, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and immunofluorescence staining were used to evaluate the potential of DFSCs to differentiate into corneal epithelial, keratocyte, or endothelial cells. The culture medium was collected every 3 days for growth factor analysis. The DFSCs cultured on the ECM exhibit notable cell-ECM adhesion and the potential to primarily differentiate into keratocytes, with a partial capacity for differentiation into corneal endothelial cells, while the cells outside the ECM are weakly affected. Growth factor array analysis revealed changes in growth factor expression in different culture conditions, DFSCs, ECM, and DFSCs/ECM co-culture at various time points, indicating a dynamic shift in the microenvironment. The present study demonstrated that DFSCs cultured on the porcine corneal ECM can differentiate mainly into keratocytes-like and partially into corneal endothelial-like cells, exhibiting strong cell-ECM adhesion and regulation of growth factors. Provide insights into the therapeutic application potential of dental-derived stem cells and SC-CO2 decellularized tissue for corneal diseases.
Retinopathy affects millions worldwide with increasing prevalence. Dental-derived mesenchymal stem cells (MSCs), primarily originating from the neural crest, possess unique neural-like properties, including high expression of neural markers, making them promising candidates for neural and retinal regenerative medicine. The present study compared two isolation methods for dental-derived MSCs and investigated the potential of dental follicle stem cells (DFSCs) to differentiate into neurons and retinal progenitor cells under defined conditions. The cells of extracted dental tissues were isolated by enzymatic digestion and explant culture methods. The multi-lineage differentiation capabilities of DFSCs were confirmed by Alizarin Red staining and Oil Red-O staining after defined culture stimulation. The differentiation of neurons and retinal progenitors was induced in DFSCs and confirmed through cell morphology, immunofluorescence staining, and western blotting. The enzymatic digestion method was faster and promoted quicker proliferation of DFSCs compared to other dental sources. The expression of Alizarin Red staining and Oil Red-O staining confirmed the multi-lineage differentiation capabilities of DFSCs. Under specific conditions, DFSCs demonstrated the potential to differentiate into neural, retinal progenitor, ganglion, bipolar, amacrine, and Müller-like cells with morphologic changes and expression of related proteins. The present study demonstrates the superior proliferation ability of DFSCs among dental cells, and possesses the potential to differentiate into retinal progenitor cells and neurons under defined conditions. Provide valuable insights into DFSCs as an effective stem cell source and their potential for future therapeutic applications in retinal-related diseases.